"In 2011, 1,925 malaria cases were reported in the United States, according to data published in a supplement of the Morbidity and Mortality Weekly Report (MMWR) released today by the Centers for Disease Control and Prevention "...
Lamprene Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Lamprene (clofazimine) Soft Gelatin Capsules is an anti-leprosy drug used to treat lepromatous leprosy. Common side effects of Lamprene include:
- changes in skin color
- dry and scaly skin
- abdominal pain
- food intolerances
- eye irritation or burning
- eye dryness
- itchy eyes
- eye discoloration
- changes in color of urine/stool/mucus
- elevated blood sugar
The recommended dosage of Lamprene is 100 mg daily. Lamprene may interact with other drugs. Tell your doctor all medications you use. Before taking Lamprene tell your doctor if you have abdominal pain, diarrhea or other stomach problems. If you are pregnant only take Lamprene if the potential benefit outweighs the potential risk to the fetus. If you are breastfeeding only take Lamprene if clearly needed.
Our Lamprene (clofazimine) Soft Gelatin Capsules Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Lamprene FDA Prescribing Information: Side Effects
In general, Lamprene (clofazimine) is well tolerated when administered in dosages no greater than 100 mg daily. The most consistent adverse reactions are usually dose related and are usually reversible when Lamprene (clofazimine) is discontinued.
Adverse Reactions Occurring In More Than 1% of Patients
Adverse Reactions Occurring In Less Than 1% of Patients
Skin:Phototoxicity, erythroderma, acneiform eruptions, monilial cheilosis.
Ocular: Diminished vision.
Psychiatric:Depression secondary to skin discoloration; two suicides have been reported.
Read the entire FDA prescribing information for Lamprene (Clofazimine)
Additional Lamprene Information
- Lamprene Drug Interactions Center: clofazimine oral
- Lamprene Side Effects Center
- Lamprene FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.